Q4 2014 13F Holders as of 12/31/2014
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
295M
-
Number of holders
-
157
-
Total 13F shares, excl. options
-
46.4M
-
Shares change
-
-1.01M
-
Total reported value, excl. options
-
$705M
-
Value change
-
-$11M
-
Put/Call ratio
-
0.06
-
Number of buys
-
65
-
Number of sells
-
-69
-
Price
-
$15.21
Significant Holders of SANGAMO THERAPEUTICS, INC - Common Stock (SGMO) as of Q4 2014
191 filings reported holding SGMO - SANGAMO THERAPEUTICS, INC - Common Stock as of Q4 2014.
SANGAMO THERAPEUTICS, INC - Common Stock (SGMO) has 157 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 46.4M shares
of 295M outstanding shares and own 15.73% of the company stock.
Largest 10 shareholders include FMR LLC (4.1M shares), WASATCH ADVISORS INC (2.97M shares), BlackRock Fund Advisors (2.54M shares), State Street Corp (2.33M shares), ADAGE CAPITAL PARTNERS GP LLC (2.3M shares), VANGUARD GROUP INC (2.15M shares), BlackRock Institutional Trust Company, N.A. (1.92M shares), FRONTIER CAPITAL MANAGEMENT CO LLC (1.86M shares), JENNISON ASSOCIATES LLC (1.71M shares), and JANUS CAPITAL MANAGEMENT LLC (1.55M shares).
This table shows the top 157 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.